Medtronic stock reports 13.7 percent Q1 revenue growth

{
  "signal_id": "8d102aca-33a5-2ba9-0736-cd3117b07ab6",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-09-28T10:37:18+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/medtronic-stock-reports-13-7-percent-q1-revenue-growth/70192312",
    "title": "Medtronic stock reports 13.7 percent Q1 revenue growth - AD HOC NEWS",
    "excerpt": "Medtronic plc (ISIN IE00BTN1Y115) reported USD 9.756 billion in first-quarter fiscal 2027 revenue, up 13.7 percent from the prior-year quarter. The September 25, 2026 closing price of USD 88.64 on the NYSE gives the stock a market value of USD 113.5 billion. According to Medtronic on September 1, 2026, first-quarter GAAP diluted EPS was USD 1.14, while non-GAAP diluted EPS reached USD 1.45. The company raised FY27 organic revenue growth guidance to 7.25 percent to 7.75 percent from 6.75 percent to 7.25 percent. The same release showed a wider contribution from the operating portfolio. Cardiovascular revenue increased 19.5 percent to USD 3.927 billion, Neuroscience revenue rose 10.3 percent to USD 2.678 billion, and Medical Surgical revenue advanced 10.0 percent to USD 2.279 billion. Yahoo Finance reported that Mizuho raised its price target from USD 100 to USD 115 and BofA lifted its target from USD 95 to USD 110 after the first-quarter results. Against the September 25 closing price, Mizuho's target stands 29.76 percent above the stock, while BofA's target is 24.11 percent higher. The targets point to optimism about Medtronic's growth acceleration, but the guidance range remains more measured than the first-quarter result. The company also reported a 53-week fiscal year, making the extra fiscal week a factor in the quarter's 13.7 percent organic growth comparison. Medtronic...",
    "summary": "Medtronic reported first-quarter fiscal 2027 GAAP diluted EPS of USD 1.14 and non-GAAP diluted EPS of USD 1.45.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2703856_1920_1080.webp",
    "confidence": 0.95,
    "published_at": "2026-09-28T10:37:18Z",
    "effective_date": "2026-09-01",
    "article_sentence": "According to Medtronic on September 1, 2026, first-quarter GAAP diluted EPS was USD 1.14, while non-GAAP diluted EPS reached USD 1.45."
  }
}

curl https://signals.autobound.ai/v1/signals/8d102aca-33a5-2ba9-0736-cd3117b07ab6 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'